T80.39XS (Other ABO incompatibility reaction due to transfusion of blood or blood products, sequela) compared with T86.01 (Bone marrow transplant rejection), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).
Distinct conditions — both may be reported.
“bone marrow transplant rejection (T86.01)”
An Excludes2 note means the excluded condition is not part of the code above it, but a patient can have both. Report both when both are documented.
Source: CMS ICD-10-CM tabular instructional notes
Yes, when both are documented. T80.39XS carries an Excludes2 note covering T86.01: “bone marrow transplant rejection (T86.01)”
Excludes2 marks distinct conditions — both may be reported when both are documented.
| T80.39XSOther ABO incompatibility reaction due to transfusion of blood or blood products, sequela | T86.01Bone marrow transplant rejection | |
|---|---|---|
| Billing status | Billable | Billable |
| Classification | S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88) | S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88) |
| Definition | Other ABO incompatibility reaction due to transfusion of blood or blood products, sequela is a billable ICD-10-CM diagnosis code (T80.39S). | Bone marrow transplant rejection is a billable ICD-10-CM diagnosis code (T86.01). |
| 7th character | The appropriate 7th character is to be added to each code from category T80 | — |
| Includes | complications following perfusion Delayed serologic transfusion reaction (DSTR) from ABO incompatibility Other ABO incompatible blood transfusion Other reaction to ABO incompatible blood transfusion | — |
| Use additional code | code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) code(s) to identify the specified condition resulting from the complication code to identify devices involved and details of circumstances (Y62-Y82) | code to identify other transplant complications, such as: graft-versus-host disease (D89.81-) malignancy associated with organ transplant (C80.2) |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources